Success Story: Neurovascular Disease Research Leads to NIW Approval Without RFE
Client’s Testimonial:
"Thank you so much for letting me know. I really appreciate your time and the work you did for my immigration case. It was a pleasure to work with your team."
On July 13th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Scholar in the Field of Neuroscience (Approval Notice).
General Field: Neuroscience
Position at the Time of Case Filing: Postdoctoral Scholar
Country of Origin: Iran
State of Residence at the Time of Filing: California
Approval Notice Date: June 24th, 2026
Processing Time: 29 months, 21 days
Case Summary:
Neuroscience research often depends on researchers who can connect clinical knowledge, disease mechanisms, and practical diagnostic tools. The client’s work focuses on developing laboratory-based (in vitro) and living-system (in vivo) experimental models to support the design, testing, and improvement of neurovascular devices used in the diagnosis and treatment of stroke, intracerebral hemorrhage, and other related neurovascular disorders. Holding an M.D., the client sought classification under the EB-2 National Interest Waiver category to continue research aimed at improving diagnostic and therapeutic approaches for serious neurovascular conditions. At the time of filing, the client was conducting research in a U.S. university setting while continuing to develop models and methods relevant to neurovascular disease research.
A central part of the petition focused on demonstrating that the client was well positioned to carry this work forward. Rather than relying on a single achievement, North America Immigration Law Group (NAILG) presented a combination of scholarly accomplishments that reflected the client’s progress in neuroscience and related medical research. The client had authored 6 peer-reviewed journal articles, including 2 first-authored publications, and the published work had accumulated 34 citations. The client had also completed at least 29 peer reviews, showing that journals recognized the client’s expertise and trusted the client to evaluate scholarly work in neuroscience and related fields.
The petition demonstrated the client’s significance by showing that the client’s research has been cited and used in related neuroscience and clinical studies. We also showed that 2 of the client’s papers ranked among the top 10% most-cited Neuroscience and Behavior articles for their publication years. These citations were presented not merely as numerical evidence, but as proof that independent researchers had relied upon the client’s findings to advance their own investigations.
Another important component of the case involved demonstrating that recognized experts viewed the client’s research as valuable. We submitted 2 recommendation letters from experts in the field, including 1 independent advisory opinion, to explain the relevance of the client’s medical background, research record, and planned work in neurovascular disease research. One expert noted:
"The applications of her research extend beyond immediate patient care, offering valuable insights for future clinical protocols and contributing to the broader field of neuroscience, ultimately improving public health standards and addressing a major public health concern."
By carefully connecting the client’s medical education, ongoing U.S. research, publication record, citation impact, peer-review service, and expert testimonials, we demonstrated that the proposed endeavor extends beyond academic inquiry and addresses issues of significant importance to public health. USCIS ultimately approved the client’s I-140 National Interest Waiver petition without an RFE, allowing the client to continue pursuing research that may contribute to improved diagnosis, treatment, and clinical outcomes for patients with stroke, intracerebral hemorrhage, and neurovascular disease in the United States.